Female Clinical Trials

9 recruiting

Female Trials at a Glance

282 actively recruiting trials for female are listed on ClinicalTrialsFinder across 6 cities in 60 countries. The largest study group is Not Applicable with 130 trials, with the heaviest enrollment activity in Houston, Boston, and Milan. Lead sponsors running female studies include ART Fertility Clinics LLC, Mayo Clinic, and University of Toronto.

Browse female trials by phase

Treatments under study

About Female Clinical Trials

Looking for clinical trials for Female? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Female trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Female clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 282 trials

Recruiting

Biorepository in Participants Who Undergo OTC for Gonadotoxic Therapy

InfertilityAcute Ovarian FailureEarly Menopause And Infertility In Females After Treatment For Childhood Cancer
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)100 enrolled1 locationNCT05440617
Recruiting
Phase 2

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

Malignant Solid NeoplasmMalignant Female Reproductive System NeoplasmRecurrent Malignant Solid Neoplasm+1 more
National Cancer Institute (NCI)70 enrolled185 locationsNCT06126276
Recruiting
Phase 2

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Malignant Female Reproductive System Neoplasm+12 more
National Cancer Institute (NCI)2,900 enrolled479 locationsNCT05564377
Recruiting
Not Applicable

Does Orientation On Eye Health To Female Health Volunteers Increase Footfall In A Vision Center

Eye DisordersFemale Community Health Volunteers
Seva Canada Society149 enrolled1 locationNCT07443683
Recruiting
Not Applicable

Feasibility and Acceptibility of a Multi-site Trial of Time Restircted Eating During Chemotheraply for Breast Cancer.

Breast CancerBreast Cancer Early Stage Breast Cancer (Stage 1-3)Breast Neoplasm Female
University of Illinois at Chicago40 enrolled2 locationsNCT07387445
Recruiting

Evaluation of Safety of Acellular Dermal Matrix(ADM) in Breast Reconstruction

Breast Cancer FemaleBreast Reconstruction
DOF Inc.120 enrolled1 locationNCT06555614
Recruiting
Phase 3

Progesterone-modified Natural Cycle for FET

Infertility, Female
Shandong University of Traditional Chinese Medicine336 enrolled1 locationNCT06644794
Recruiting
Phase 2Phase 3

Uterine Transplant in Absolute Uterine Infertility (AUIF)

Female Infertility
Brigham and Women's Hospital10 enrolled1 locationNCT02741102
Recruiting
Not Applicable

TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients

Breast CancerBreast Cancer FemaleStage III Breast Cancer+2 more
Dana-Farber Cancer Institute270 enrolled3 locationsNCT05535192
Recruiting
Not Applicable

The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System

Polycystic Ovary SyndromeInfertility, Female
May Health195 enrolled23 locationsNCT06206746
Recruiting
Not Applicable

Randomized Study of a Dematerialized Management for Post-Emergency Gynecological Follow-Up

Genital Diseases, FemaleEctopic PregnancyUncertain Viability of Pregnancy+1 more
Assistance Publique - Hôpitaux de Paris200 enrolled1 locationNCT06615843
Recruiting
Not Applicable

Clinical Relevance of Modifying RANKL Signaling During Folliculogenesis

OsteoporosisFemale InfertilityNF-κB Ligand+2 more
Peter Humaidan100 enrolled1 locationNCT07546552
Recruiting
Phase 2

Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer

Anal CarcinomaCervical CarcinomaVaginal Carcinoma+3 more
Ohio State University Comprehensive Cancer Center25 enrolled1 locationNCT07407647
Recruiting
Not Applicable

Impact of CMG vs VCMG in Recurrent Stress Incontinence- A Pilot Study

Stress Incontinence FemaleUrodynamic Exam
University College, London30 enrolled1 locationNCT07542080
Recruiting
Not Applicable

Endometrial Immune Profile Changes After Autologous Intrauterine PRP Treatment

Female InfertilityIVF Patients
Nadezhda Women's Health Hospital50 enrolled1 locationNCT07535190
Recruiting
Phase 1

A Study of ORN252 in Healthy Participants

Healthy Volunteers - Male and Female
Orna Therapeutics, Inc.20 enrolled1 locationNCT07439796
Recruiting
Not Applicable

Examining Olive Oil Extract on Knee Comfort and Function

Healthy Adult MaleJoint DiscomfortHealthy Adult Females
Applied Food Sciences Inc.168 enrolled1 locationNCT07514013
Recruiting
Phase 3

A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2)

Breast Neoplasm FemaleRadiotherapyCosmetic Outcome
Ontario Clinical Oncology Group (OCOG)910 enrolled28 locationsNCT05417516
Recruiting
Phase 1Phase 2

ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer

Breast CancerMetastatic Breast CancerBreast Cancer Female+2 more
Sarah Sammons, MD65 enrolled1 locationNCT07198724
Recruiting

Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study

Malignant Female Reproductive System NeoplasmMalignant Genitourinary System NeoplasmMalignant Digestive System Neoplasm
Wake Forest University Health Sciences500 enrolled59 locationsNCT07215624